Internal Reference Number: FOI_7988
Date Request Received: 10/06/2024 00:00:00
Date Request Replied To: 24/06/2024 00:00:00
This response was sent via: By Email
Request Summary: Weightloss drugs
Request Category: Media
| Question Number 1: How many A&E appointments were taken where an overdose of either Saxenda, ozempic or wegovy (medical names Liraglutide and semaglutide) weightloss drugs were given as a reason for the appointment in every year between 2018 and 2023. Please give a figure for each year. | |
| Answer To Question 1: Our searches have found 0 results for patients attending ED where an overdose of either Saxenda, ozempic or wegovy (medical names Liraglutide and semaglutide) weightloss drugs were given as a reason for the attendance. | |
| Question Number 2: How many deaths were recorded where an overdose of either Saxenda, ozempic or wegovy (medical names Liraglutide and semaglutide) weightloss drugs were given as a reason in every year between 2018 and 2023. Please give a figure for each year. | |
| Answer To Question 2: Our searches have found 0 results for patient deaths where an overdose of either Saxenda, ozempic or wegovy (medical names Liraglutide and semaglutide) weightloss drugs were given as a reason for the death. | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of 看片软件 Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
